Search for: "Gilead Sciences Inc." Results 121 - 140 of 182
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jan 2021, 8:11 am by Tina G. Yin Sowatzke, Pharm.D.
This particular case involved a new generation of drugs for the treatment of hepatitis C, where Idenix accused Gilead Sciences, Inc. [read post]
14 Aug 2017, 1:36 pm
• Business travel is not required.To apply, visit http://apptrkr.com/1060195As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. [read post]
14 Jun 2012, 11:55 am by Stephen Jenei
Gilead Sciences is set to climb the most positions within the top 20, moving up seven places to number 15 with prescription sales of $15.1 billion in 2018, thanks in large part to the company’s strong HIV franchise and impressive forecasts for GS-7977, its recently acquired development stage hepatitis C product. [read post]
12 Apr 2020, 6:03 am by Kluwer Patent blogger
As the Financial Times reported, Gilead Sciences renounced an orphan drug designation in the US that granted special status to its potential coronavirus treatment remdesivir. [read post]
9 May 2017, 4:42 am
Arnold J. reiterated his view (expressed previously in Teva UK Ltd v Gilead Sciences Inc [2017] EWHC 13 (Pat)) that the test in Lilly remains unclear. [read post]
1 Apr 2008, 2:32 am
There is no unitary European supplementary protection certificate, but national ones only.According to Burrows,In [in Re Gilead Sciences, Inc.] an application was made for an SPC in respect of EP (UK) 0 915 894 and the combination of two antiretroviral compounds, namely tenofovir disoproxil and emtricitabine. [read post]
25 Oct 2011, 10:00 am by Lucas A. Ferrara, Esq.
The study was published online in Cell Host and Microbes and was conducted by researchers at the Catholic University of Leuven, Belgium; the University of Rome; Gilead Sciences, Inc., Foster City, Calif; and the NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). [read post]
5 Sep 2023, 2:39 am by Courtenay C. Brinckerhoff
Cellect Strategies  Some stakeholders have been expecting a decision like Cellect since the Federal Circuit first decided that a later-granted patent can raise OTDP issues for an earlier-granted patent, in its 2014 decision in Gilead Sciences, Inc. v. [read post]
31 Mar 2022, 10:50 am by Katherine Pompilio
The Justice Department will reportedly probe at least a dozen pharmaceutical companies such as Gilead Sciences Inc, Johnson & Johnson and GlaxoSmithKline PLC’s ViiV Healthcare. [read post]
19 Dec 2015, 1:52 pm by Michael B. Cohen, P.A.
According to the SEC complaint, the meeting was held on November 8, 2011 to discuss a year-end tax planning session which during its course released material confidential information to the three men, specifically that the company was about to be bought out by Gilead Sciences, a major pharmaceutical company; for an amount that would result in a much higher stock price for Pharmasset. [read post]
19 Dec 2015, 1:52 pm by Michael B. Cohen, P.A.
According to the SEC complaint, the meeting was held on November 8, 2011 to discuss a year-end tax planning session which during its course released material confidential information to the three men, specifically that the company was about to be bought out by Gilead Sciences, a major pharmaceutical company; for an amount that would result in a much higher stock price for Pharmasset. [read post]
6 Oct 2006, 1:22 pm
Gilead Sciences said it would buy drug developer Myogen Inc. of Colorado for $2.5 billion. [read post]
5 Oct 2020, 2:00 am by Annsley Merelle Ward
Settle in with the Chat Français for some French carb loading of delicious, fresh patent decisions from the first half of 2020Finding it difficult to keep up with an ever-changing world in the midst of a health, environmental, social and political crisis, while keeping up with patent law? [read post]
Gilead Sciences, Inc., (discussion by C&M attorneys here), the panel held that Escobar’s two conditions must be satisfied to give rise to an implied-certification claim. [read post]
7 Dec 2014, 3:29 pm
‘It’s Idenix Pharmaceutical, Inc v Gilead Sciences, Inc & Others [2014] EWHC 3916 (Pat) (01 December 2014)’, Darren might answer. [read post]
12 May 2020, 4:00 am by Alan Macek
Gilead Sciences Canada, Inc., 2020 FC 486, another decision decided by Justice Manson, the defendant sought summary trial on the meaning of a key term of the asserted patent claims and non-infringement. [read post]